ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,312, issued on Aug. 4, was assigned to UNIVERSITA' DEGLI STUDI DI MILANO (Milan), UNIVERSITA' DEGLI STUDI DI ROMA "TOR VERGATA" (Rome) and UNIVERSITA' POLITECNICA DELLE MARCHE (Ancona, Italy).
"JNK3 inhibitory peptides" was invented by Tiziana Borsello (Milan), Mattia Falconi (Rome) and Daniele Di Marino (Ancona, Italy).
According to the abstract* released by the U.S. Patent & Trademark Office: "The subject of the present invention is a peptide, natural or synthetic, which comprises an amino acid sequence that has at least 80% sequence identity with the sequence SDRSLHLEANEKGENVNVHVTKTRADKSKIKVSVRQYADINEKGEAQYKCPVAQLE (SEQ ID NO: 1). A further object of the present invention is sa...